Grad Intern – Biophysical Assay Technology Development (Summer 2027)
Amgen
Summary
During this program, you will evaluate and advance high-throughput Spectral Shift and optical protein-unfolding thermal-shift assays to support small-molecule binder screening and hit validation.
Job description
What You Will Do
During this program, you will evaluate and advance high-throughput Spectral Shift and optical protein-unfolding thermal-shift assays to support small-molecule binder screening and hit validation.
- Assess the performance, reproducibility, and data quality of a high-throughput Spectral Shift workflow for small-molecule binder screening
- Optimize optical protein-unfolding thermal-shift assay conditions and evaluate their use for hit validation
- Design and conduct experiments using protein targets, reference compounds, and biophysical assay methods
- Analyze experimental results, document methods and findings, and communicate conclusions to the project team
- Collaborate with scientists to develop assay workflows and identify opportunities to apply these technologies in small-molecule drug discovery
Program Eligibility Requirements
- Must be available to work a full-time schedule
- Expected continued enrollment in an accredited college or university following the internship program / co-op
- Student must be located in the United States for the duration of the internship program
Basic Qualifications
- 18 years or older
- Graduated with a bachelor’s degree from an accredited college or university
- Currently enrolled in an MBA program for an MBA internship OR a Master’s program for a Master’s internship OR a PharmD program for a PharmD internship OR Ph.D. for a PhD internship from an accredited college or university and completion of the first year of MBA OR Master’s OR Pharm D OR Ph.D. program before the internship starts
Preferred Qualifications
- Degree concentration(s) in biochemistry, biophysics, chemistry, chemical biology, molecular biology, biotechnology, or a related discipline
- Hands-on laboratory experience with biochemical or biophysical assays, purified proteins, or assay development
- Familiarity with fluorescence-based assays, protein stability or thermal-shift methods, high-throughput screening, or laboratory automation
- Strong experimental organization, data analysis, scientific documentation, and communication skills
Requirements
- Must be available to work a full-time schedule
- Expected continued enrollment in an accredited college or university following the internship program / co-op
- Student must be located in the United States for the duration of the internship program
- 18 years or older
- Graduated with a bachelor’s degree from an accredited college or university
- Currently enrolled in an MBA, Master’s, PharmD, or Ph.D. program and completion of the first year before the internship starts
- Candidates must be authorized to work in the U.S. for the duration of this program
Benefits
- Networking Events
- Community Volunteer Projects
- Competitive Benefits
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.